尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Squarer Ron, 董事. Officer active across 3 companies, notably Travere Therapeutics, Inc.. Aggregated, 13 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €19k. History available since 14 May 2021. The latest transaction was disclosed on 3 June 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 条申报中的 13 条
Squarer Ron is Administrateur at ADC Therapeutics SA, Travere Therapeutics, Inc. and Nuvalent, Inc. He has 13 filings in total; across the 13 most recent sampled filings, the observed amounts are EUR 0 in purchases and EUR 18821 in sales, from 2021-05-18 to 2026-07-15. The most frequent transaction nature is Attribution.